protein mediator
Recently Published Documents


TOTAL DOCUMENTS

10
(FIVE YEARS 1)

H-INDEX

7
(FIVE YEARS 0)

Diagnostics ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 860
Author(s):  
Mohit Kakar ◽  
Marisa Maija Berezovska ◽  
Renars Broks ◽  
Lasma Asare ◽  
Mathilde Delorme ◽  
...  

Purpose: This prospective, single-center cohort study analyzes the potential of inflammatory protein mediator leucine-rich alpha-2 glycoprotein 1 (LRG1) for the early and accurate diagnosis of acute appendicitis (AA), and differentiation of acute complicated (AcA) from uncomplicated appendicitis (AuA). Methods: Participants were divided into the AcA, AuA, and control groups, and their serum (s-LRG1) and urine LRG1 (u-LRG1) levels were assayed preoperatively on the second and fifth postoperative days. Results: 153 patients participated, 97 had AA. Preoperative u-LRG1 with a cut-off value of 0.18 μg/mL generated an area under the receiver operated characteristic (AUC) curve of 0.70 (95% CI 0.62–0.79) for AA versus control (p < 0.001), while the results for AcA versus AuA were not significant (AUC 0.60, 95% CI 0.49–0.71, p = 0.089). The s-LRG1 levels of AA versus the control with a cut-off value of 51.69 μg/mL generated an AUC of 0.94 (95% CI 0.91–0.99, p < 0.001). The cut-off value of s-LRG1 was 84.06 μg/mL for diagnosis of AcA from AuA, and therefore, significant (AUC 0.69, 95% CI 0.59–0.80, p = 0.001). Conclusions: LRG1 exhibited excellent diagnostic performance as an inexpensive, non-invasive, rapid, and accurate biomarker able to reflect the pathogenesis of AA. LRG1 has the potential to replace advanced imaging to diagnose clinically ambiguous AA cases.


2020 ◽  
Vol 16 (4) ◽  
pp. 187-188 ◽  
Author(s):  
Jacob I. Ayers ◽  
Stanley B. Prusiner

2002 ◽  
Vol 277 (41) ◽  
pp. 38855-38862 ◽  
Author(s):  
Peter K. M. Kim ◽  
Yinna Wang ◽  
Andrea Gambotto ◽  
Young-Myeong Kim ◽  
Richard Weller ◽  
...  

2000 ◽  
Vol 349 (1) ◽  
pp. 99-104 ◽  
Author(s):  
Ana CRESPO ◽  
Michael B. FILLA ◽  
Stephen W. RUSSELL ◽  
William J. MURPHY

It has previously been reported by us that a brief prior exposure of mouse bone marrow culture-derived macrophages to bacterial lipopolysaccharide (LPS) resulted in a dramatic reduction in their ability to produce NO in response to a subsequent stimulus with either interferon-γ (IFN-γ) or IFN-γ plus LPS. We show here that this brief exposure to LPS results in an impaired response to subsequently added IFN-γ. A 2-4 h pretreatment with LPS leads to a dramatic reduction in the IFN-γ-induced DNA-binding of the transcription factor, signal transducer and activator of transcription 1α (STAT1α). This loss in ability to activate STAT1α temporally correlates with the LPS-induced accumulation of mRNA encoding the suppressor of cytokine signalling-1 (SOCS-1). However, LPS does not directly induce the synthesis of SOCS-1. Rather, LPS induces the synthesis of autocrine/paracrine factors that are the true mediators of SOCS-1 induction. IFN-α/β is one of these mediators, but plays only a partial role in the induction of SOCS-1 because neutralization of LPS-induced IFN-α/β production incompletely inhibits the induction of SOCS-1. We show that mouse IFN-β directly induces the synthesis of SOCS-1, without the need for prior protein synthesis, and does so with faster kinetics than does LPS. Our results are consistent with the non-specific nature of LPS-induced tolerance and provide a mechanistic insight into nonspecificity; LPS indirectly induces the synthesis of a protein mediator, SOCS-1, which inhibits the signalling that is induced by IFN-γ.


1998 ◽  
Vol 158 (3) ◽  
pp. 319-325 ◽  
Author(s):  
M Datta ◽  
P Roy ◽  
J Banerjee ◽  
S Bhattacharya

Blood samples collected from 29 women (aged between 19 and 35 years) during the luteal phase of the menstrual cycle (between days 18 and 23 of the cycle) showed that deficiency in thyroid hormone level is related to a decrease in progesterone (P4) secretion. To observe the effect of thyroid hormone on human ovarian luteal cells, 3,5,3'-triiodothyronine (T3; 125 ng/ml) was added to luteal cells in vitro. T3 significantly stimulated progesterone release (P < 0.01) from luteal cells and this could be blocked by cycloheximide, indicating a protein mediator for the T3 effect. The T3 stimulatory effect was inhibited by anti-T3 antibody suggesting specificity of T3 action. Addition of T3 caused a more than threefold increase in cellular protein synthesis which was inhibited by cycloheximide. Preparation of partially purified thyroid hormone-induced factor (TIF) (from peak II of Sephadex G 100 chromatography of T3-incubated cells), and its addition to luteal cell incubations caused a significant increase in P4 release (P < 0.05). Incubation with trypsin or treatment with heat destroyed the stimulatory effect of TIF on P4 release, indicating the proteinaceous nature of TIF. Purified thyroid hormone-induced protein. (TIP) from rat granulosa cells and fish ovarian follicles greatly stimulated P4 release from human luteal cells. These results suggest that T3 stimulation of P4 release from human luteal cells is not direct, but is mediated through a putative protein factor, which appears to be a protein conserved through evolution as far as its biological activity is concerned.


1993 ◽  
Vol 10 (1) ◽  
pp. 7-13 ◽  
Author(s):  
M Angervo ◽  
P Leinonen ◽  
R Koistinen ◽  
M Julkunen ◽  
M Seppälä

ABSTRACT The growth-regulating actions of IGFs are modulated by their binding proteins (IGFBPs). The serum concentration of IGFBP-1 is down-regulated by insulin, and in-vitro studies have demonstrated that IGFBP-1 secretion from various tissues and cells can be stimulated by theophylline, forskolin, oestrogen and progesterone. We have studied the effects and mechanisms of thyroid hormone action on IGFBP-1 gene expression and secretion by human hepatoma cells in vitro. Tri-iodothyronine dose-dependently enhanced IGFBP-1 secretion in serum-free HepG2 cell cultures after 24–48 h of exposure, as measured by a specific immunofluorometric assay. This was accompanied by an increase (+ 50%) in the amount of IGFBP-1 mRNA, which could be prevented by cycloheximide, a protein synthesis inhibitor. Cycloheximide transiently enhanced (+ 200%) the accumulation of IGFBP-1 mRNA at 3–12 h of incubation, when no effect of tri-iodothyronine was observed. It is concluded that thyroid hormone stimulates IGFBP-1 secretion slowly by enhancing IGFBP-1 gene expression by a protein mediator. The acute stimulation of IGFBP-1 gene transcription by cycloheximide associates this gene with a number of growth-related genes encoding growth- and tumour-associated peptides.


1982 ◽  
Vol 21 (10) ◽  
pp. 1065-1072 ◽  
Author(s):  
S.B. Kandasamy ◽  
B.A. Williams

1978 ◽  
Vol 172 (3) ◽  
pp. 605-611 ◽  
Author(s):  
W J Mawby ◽  
J B C Findlay

A comparison was made between the phosphate- and glucose-transport systems of intact erythrocytes and resealed washed membranes. Glucose transport exhibits identical properties in both cases, but the phosphate-transport system does not appear to have survived the membrane isolation procedure unaltered. Evidence is presented to support the suggestion that some form of structural perturbation has occurred to the protein mediator of phosphate exchange.


Sign in / Sign up

Export Citation Format

Share Document